Excellere Partners has hired Michael Geldart as Partner. Most recently, Geldart was the Chief Operating Officer of BioTelemetry.
DENVER–(BUSINESS WIRE)–Excellere Partners, a leading Denver-based private equity firm specializing in partnering with entrepreneurs and management teams through recapitalizations and management buyouts, is pleased to announce that it has hired Michael Geldart as Partner.
David Kessenich, Managing Partner and Co-Founder of Excellere Partners commented, “We are excited to welcome Michael to Excellere Partners. He is a strategic-minded, results-oriented leader with an entrepreneurial mindset. With his vast healthcare experience in legal, regulatory compliance and operations, Michael will be an extremely value-added team member to our current and future healthcare investments.”
Michael Geldart has more than 20 years of experience in executive leadership, health law, and corporate development. Most recently, Michael was the Chief Operating Officer of BioTelemetry (Nasdaq:BEAT), the leading provider of cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. Prior to joining BioTelemetry in 2012, Michael was the Chief Operating Officer of MedExpress (a former portfolio company of Excellere Partners), a leading multi-state Urgent Care provider. Prior to joining MedExpress, Michael was the Chief Operating Officer and EVP of Corporate Development of CCS Medical, a national provider of Medical and Pharmacy supplies for patients suffering from diabetes, respiratory and other chronic conditions. Prior to CCS Medical, Michael was a partner at Holland & Knight, LLP, a global law firm, serving as the Co-Chair of the firm’s National Health Care Practice Group. Michael received a Bachelor of Arts in Chemistry from the University of South Florida, and Juris Doctor degree from Stetson University College of Law. Michael is a member of the Florida Bar.
About Excellere Partners
Excellere Partners is a Denver-based private equity firm with $1.36 billion of committed capital across three funds, and specializes in partnering with entrepreneurs and management teams through recapitalizations and management buyouts. The Firm employs a proven research-driven, top down investment strategy, and supports its entrepreneurs and management teams with a proprietary value creation process designed to enhance corporate and operational infrastructure for scalability and growth. Excellere’s investments are focused on differentiated and growth oriented companies positioned to benefit from industry consolidation and favorable macro-economic and demographic trends. The Firm’s targeted industry sectors include healthcare services and products; energy and utility products and services; industrial technology and services; business services; and agri-business. For more information about Excellere, please visithttp://www.excellerepartners.com